APO Research
Talk to an analyst

APO RESEARCH · REPORT

Treprostinil

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Treprostinil Market Outlook and Growth Opportunities 2026

22 December 2025193 pages

Choose your research edition.

Industry ResearchTreprostinil Industry Research Report 2026110 pages · $2,950 USDIndustry Growth & TrendsGlobal Treprostinil Industry Growth and Trends Forecast to 203279 pages · $3,450 USDMarket StructureGlobal Treprostinil Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032170 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Treprostinil Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Treprostinil Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Treprostinil market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Treprostinil is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Treprostinil is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Treprostinil is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Treprostinil market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Treprostinil market include Sandoz, Anhui Medipharm Co., Ltd., United Therapeutics Corporation and TYVASO, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Treprostinil market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Treprostinil and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Treprostinil sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Treprostinil market size, projected growth trends, production technologies, key applications, and end-use industries.

Treprostinil Segment by Company

Sandoz

Anhui Medipharm Co., Ltd.

United Therapeutics Corporation

TYVASO

Treprostinil Segment by Type

Injection

Inhalation form

Treprostinil Segment by Application

Hospital

Drug store

Treprostinil Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Treprostinil status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Treprostinil market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Treprostinil significant trends, drivers, influence factors in global and regions.

6. To analyze Treprostinil competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Treprostinil market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Treprostinil and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Treprostinil.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Treprostinil market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Treprostinil industry.

Chapter 3: Detailed analysis of Treprostinil manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Treprostinil in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Treprostinil in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Treprostinil Industry Trends Table 2. Treprostinil Industry Drivers Table 3. Treprostinil Industry Opportunities and Challenges Table 4. Treprostinil Industry Restraints Table 5. Global Treprostinil Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Treprostinil Revenue Share by Company (2021-2026) Table 7. Global Treprostinil Sales Volume by Company (k units) & (2021-2026) Table 8. Global Treprostinil Sales Volume Share by Company (2021-2026) Table 9. Global Treprostinil Average Price (US$/unit) of Company (2021-2026) Table 10. Global Treprostinil Company Ranking, (2024-2026) & (USD Million) Table 11. Global Treprostinil Key Company Manufacturing Base & Headquarters Table 12. Global Treprostinil Company, Product Type & Application Table 13. Global Treprostinil Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Treprostinil by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Injection Table 18. Significant Companies of Inhalation form Table 19. Global Treprostinil Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 20. Global Treprostinil Sales Volume by Type (2021-2026) & (k units) Table 21. Global Treprostinil Sales Volume by Type (2027-2032) & (k units) Table 22. Global Treprostinil Sales Volume Share by Type (2021-2026) Table 23. Global Treprostinil Sales Volume Share by Type (2027-2032) Table 24. Global Treprostinil Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Treprostinil Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Treprostinil Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Treprostinil Sales Value Share by Type (2021-2026) Table 28. Global Treprostinil Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Hospital Table 30. Significant Companies of Drug store Table 31. Global Treprostinil Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 32. Global Treprostinil Sales Volume by Application (2021-2026) & (k units) Table 33. Global Treprostinil Sales Volume by Application (2027-2032) & (k units) Table 34. Global Treprostinil Sales Volume Share by Application (2021-2026) Table 35. Global Treprostinil Sales Volume Share by Application (2027-2032) Table 36. Global Treprostinil Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Treprostinil Sales Value by Application (2021-2026) & (US$ Million) Table 38. Global Treprostinil Sales Value by Application (2027-2032) & (US$ Million) Table 39. Global Treprostinil Sales Value Share by Application (2021-2026) Table 40. Global Treprostinil Sales Value Share by Application (2027-2032) Table 41. Global Treprostinil Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 42. Global Treprostinil Sales by Region (2021-2026) & (k units) Table 43. Global Treprostinil Sales Market Share by Region (2021-2026) Table 44. Global Treprostinil Sales by Region (2027-2032) & (k units) Table 45. Global Treprostinil Sales Market Share by Region (2027-2032) Table 46. Global Treprostinil Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Treprostinil Sales Value by Region (2021-2026) & (US$ Million) Table 48. Global Treprostinil Sales Value Share by Region (2021-2026) Table 49. Global Treprostinil Sales Value by Region (2027-2032) & (US$ Million) Table 50. Global Treprostinil Sales Value Share by Region (2027-2032) Table 51. Global Treprostinil Market Average Price (US$/unit) by Region (2021-2026) Table 52. Global Treprostinil Market Average Price (US$/unit) by Region (2027-2032) Table 53. Global Treprostinil Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 54. Global Treprostinil Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global Treprostinil Sales by Country (2021-2026) & (k units) Table 56. Global Treprostinil Sales Market Share by Country (2021-2026) Table 57. Global Treprostinil Sales by Country (2027-2032) & (k units) Table 58. Global Treprostinil Sales Market Share by Country (2027-2032) Table 59. Global Treprostinil Sales Value by Country (2021-2026) & (US$ Million) Table 60. Global Treprostinil Sales Value Market Share by Country (2021-2026) Table 61. Global Treprostinil Sales Value by Country (2027-2032) & (US$ Million) Table 62. Global Treprostinil Sales Value Market Share by Country (2027-2032) Table 63. Sandoz Company Information Table 64. Sandoz Business Overview Table 65. Sandoz Treprostinil Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 66. Sandoz Treprostinil Product Portfolio Table 67. Sandoz Recent Development Table 68. Anhui Medipharm Co., Ltd. Company Information Table 69. Anhui Medipharm Co., Ltd. Business Overview Table 70. Anhui Medipharm Co., Ltd. Treprostinil Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 71. Anhui Medipharm Co., Ltd. Treprostinil Product Portfolio Table 72. Anhui Medipharm Co., Ltd. Recent Development Table 73. United Therapeutics Corporation Company Information Table 74. United Therapeutics Corporation Business Overview Table 75. United Therapeutics Corporation Treprostinil Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 76. United Therapeutics Corporation Treprostinil Product Portfolio Table 77. United Therapeutics Corporation Recent Development Table 78. TYVASO Company Information Table 79. TYVASO Business Overview Table 80. TYVASO Treprostinil Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 81. TYVASO Treprostinil Product Portfolio Table 82. TYVASO Recent Development Table 83. Key Raw Materials Table 84. Raw Materials Key Suppliers Table 85. Treprostinil Distributors List Table 86. Treprostinil Customers List Table 87. Research Programs/Design for This Report Table 88. Authors List of This Report Table 89. Secondary Sources Table 90. Primary Sources List of Figures Figure 1. Treprostinil Product Image Figure 2. Global Treprostinil Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Treprostinil Sales Value (2021-2032) & (US$ Million) Figure 4. Global Treprostinil Sales (2021-2032) & (k units) Figure 5. Global Treprostinil Sales Average Price (US$/unit) & (2021-2032) Figure 6. Global Treprostinil Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Injection Image Figure 10. Inhalation form Image Figure 11. Global Treprostinil Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 12. Global Treprostinil Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Treprostinil Sales Volume Share by Type (2021-2032) Figure 14. Global Treprostinil Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Treprostinil Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Treprostinil Sales Value Share by Type (2021-2032) Figure 17. Hospital Image Figure 18. Drug store Image Figure 19. Global Treprostinil Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 20. Global Treprostinil Sales Volume Share 2021 VS 2025 VS 2032 Figure 21. Global Treprostinil Sales Volume Share by Application (2021-2032) Figure 22. Global Treprostinil Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Treprostinil Sales Value Share 2021 VS 2025 VS 2032 Figure 24. Global Treprostinil Sales Value Share by Application (2021-2032) Figure 25. Global Treprostinil Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 26. Global Treprostinil Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 27. Global Treprostinil Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 28. Global Treprostinil Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 29. North America Treprostinil Sales Value (2021-2032) & (US$ Million) Figure 30. North America Treprostinil Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Europe Treprostinil Sales Value (2021-2032) & (US$ Million) Figure 32. Europe Treprostinil Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Asia-Pacific Treprostinil Sales Value (2021-2032) & (US$ Million) Figure 34. Asia-Pacific Treprostinil Sales Value Share by Country (%), 2025 VS 2032 Figure 35. South America Treprostinil Sales Value (2021-2032) & (US$ Million) Figure 36. South America Treprostinil Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Middle East & Africa Treprostinil Sales Value (2021-2032) & (US$ Million) Figure 38. Middle East & Africa Treprostinil Sales Value Share by Country (%), 2025 VS 2032 Figure 39. USA Treprostinil Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. USA Treprostinil Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. USA Treprostinil Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Canada Treprostinil Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Canada Treprostinil Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Canada Treprostinil Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Mexico Treprostinil Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Mexico Treprostinil Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Mexico Treprostinil Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Germany Treprostinil Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Germany Treprostinil Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Germany Treprostinil Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. France Treprostinil Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. France Treprostinil Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. France Treprostinil Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. U.K. Treprostinil Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. U.K. Treprostinil Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. U.K. Treprostinil Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Italy Treprostinil Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Italy Treprostinil Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Italy Treprostinil Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Spain Treprostinil Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Spain Treprostinil Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Spain Treprostinil Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Russia Treprostinil Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Russia Treprostinil Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Russia Treprostinil Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Netherlands Treprostinil Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Netherlands Treprostinil Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Netherlands Treprostinil Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Nordic Countries Treprostinil Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Nordic Countries Treprostinil Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Nordic Countries Treprostinil Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. China Treprostinil Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. China Treprostinil Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. China Treprostinil Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Japan Treprostinil Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Japan Treprostinil Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Japan Treprostinil Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. South Korea Treprostinil Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. South Korea Treprostinil Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. South Korea Treprostinil Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. India Treprostinil Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. India Treprostinil Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. India Treprostinil Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Australia Treprostinil Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Australia Treprostinil Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Australia Treprostinil Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Southeast Asia Treprostinil Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Southeast Asia Treprostinil Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Southeast Asia Treprostinil Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Brazil Treprostinil Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Brazil Treprostinil Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Brazil Treprostinil Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Argentina Treprostinil Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Argentina Treprostinil Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Argentina Treprostinil Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Chile Treprostinil Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Chile Treprostinil Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Chile Treprostinil Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Colombia Treprostinil Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Colombia Treprostinil Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Colombia Treprostinil Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Peru Treprostinil Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Peru Treprostinil Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Peru Treprostinil Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Saudi Arabia Treprostinil Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Saudi Arabia Treprostinil Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Treprostinil Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Israel Treprostinil Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Israel Arabia Treprostinil Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Israel Arabia Treprostinil Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. UAE Treprostinil Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. UAE Treprostinil Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. UAE Treprostinil Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Turkey Treprostinil Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Turkey Treprostinil Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Turkey Treprostinil Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Iran Treprostinil Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Iran Treprostinil Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Iran Treprostinil Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Egypt Treprostinil Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Egypt Treprostinil Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Egypt Treprostinil Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Treprostinil Value Chain Figure 124. Manufacturing Cost Structure Figure 125. Treprostinil Sales Mode & Process Figure 126. Direct Comparison with Distribution Share Figure 127. Distributors Profiles Figure 128. Years Considered Figure 129. Research Process Figure 130. Key Executives Interviewed

Scope & coverage.

Types
  • Injection
  • Inhalation form
Applications
  • Hospital
  • Drug store
Companies covered
  • Sandoz
  • Anhui Medipharm Co., Ltd.
  • United Therapeutics Corporation
  • TYVASO

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Treprostinil Sales Value (2021-2032)
  4. 1.2.2 Global Treprostinil Sales Volume (2021-2032)
  5. 1.2.3 Global Treprostinil Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Treprostinil Market Dynamics
  1. 2.1 Treprostinil Industry Trends
  2. 2.2 Treprostinil Industry Drivers
  3. 2.3 Treprostinil Industry Opportunities and Challenges
  4. 2.4 Treprostinil Industry Restraints
3 Treprostinil Market by Company
  1. 3.1 Global Treprostinil Company Revenue Ranking in 2025
  2. 3.2 Global Treprostinil Revenue by Company (2021-2026)
  3. 3.3 Global Treprostinil Sales Volume by Company (2021-2026)
  4. 3.4 Global Treprostinil Average Price by Company (2021-2026)
  5. 3.5 Global Treprostinil Company Ranking (2024-2026)
  6. 3.6 Global Treprostinil Company Manufacturing Base and Headquarters
  7. 3.7 Global Treprostinil Company Product Type and Application
  8. 3.8 Global Treprostinil Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Treprostinil Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Treprostinil Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Treprostinil Market by Type
  1. 4.1 Treprostinil Type Introduction
  2. 4.1.1 Injection
  3. 4.1.2 Inhalation form
  4. 4.2 Global Treprostinil Sales Volume by Type
  5. 4.2.1 Global Treprostinil Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Treprostinil Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Treprostinil Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Treprostinil Sales Value by Type
  9. 4.3.1 Global Treprostinil Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Treprostinil Sales Value by Type (2021-2032)
  11. 4.3.3 Global Treprostinil Sales Value Share by Type (2021-2032)
5 Treprostinil Market by Application
  1. 5.1 Treprostinil Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Drug store
  4. 5.2 Global Treprostinil Sales Volume by Application
  5. 5.2.1 Global Treprostinil Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Treprostinil Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Treprostinil Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Treprostinil Sales Value by Application
  9. 5.3.1 Global Treprostinil Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Treprostinil Sales Value by Application (2021-2032)
  11. 5.3.3 Global Treprostinil Sales Value Share by Application (2021-2032)
6 Treprostinil Regional Sales and Value Analysis
  1. 6.1 Global Treprostinil Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Treprostinil Sales by Region (2021-2032)
  3. 6.2.1 Global Treprostinil Sales by Region: 2021-2026
  4. 6.2.2 Global Treprostinil Sales by Region (2027-2032)
  5. 6.3 Global Treprostinil Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Treprostinil Sales Value by Region (2021-2032)
  7. 6.4.1 Global Treprostinil Sales Value by Region: 2021-2026
  8. 6.4.2 Global Treprostinil Sales Value by Region (2027-2032)
  9. 6.5 Global Treprostinil Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Treprostinil Sales Value (2021-2032)
  12. 6.6.2 North America Treprostinil Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Treprostinil Sales Value (2021-2032)
  15. 6.7.2 Europe Treprostinil Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Treprostinil Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Treprostinil Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Treprostinil Sales Value (2021-2032)
  21. 6.9.2 South America Treprostinil Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Treprostinil Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Treprostinil Sales Value Share by Country, 2025 VS 2032
7 Treprostinil Country-level Sales and Value Analysis
  1. 7.1 Global Treprostinil Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Treprostinil Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Treprostinil Sales by Country (2021-2032)
  4. 7.3.1 Global Treprostinil Sales by Country (2021-2026)
  5. 7.3.2 Global Treprostinil Sales by Country (2027-2032)
  6. 7.4 Global Treprostinil Sales Value by Country (2021-2032)
  7. 7.4.1 Global Treprostinil Sales Value by Country (2021-2026)
  8. 7.4.2 Global Treprostinil Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Treprostinil Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Treprostinil Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Treprostinil Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Treprostinil Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Treprostinil Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Treprostinil Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Treprostinil Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Treprostinil Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Treprostinil Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Treprostinil Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Treprostinil Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Treprostinil Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Treprostinil Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Treprostinil Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Treprostinil Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Treprostinil Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Treprostinil Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Treprostinil Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Treprostinil Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Treprostinil Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Treprostinil Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Treprostinil Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Treprostinil Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Treprostinil Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Treprostinil Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Treprostinil Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Treprostinil Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Treprostinil Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Treprostinil Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Treprostinil Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Treprostinil Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Treprostinil Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Treprostinil Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Treprostinil Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Treprostinil Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Treprostinil Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Treprostinil Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Treprostinil Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Treprostinil Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Treprostinil Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Treprostinil Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Treprostinil Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Treprostinil Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Treprostinil Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Treprostinil Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Treprostinil Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Treprostinil Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Treprostinil Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Treprostinil Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Treprostinil Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Treprostinil Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Treprostinil Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Treprostinil Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Treprostinil Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Treprostinil Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Treprostinil Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Treprostinil Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Treprostinil Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Treprostinil Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Treprostinil Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Treprostinil Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Treprostinil Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Treprostinil Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Treprostinil Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Treprostinil Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Treprostinil Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Treprostinil Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Treprostinil Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Treprostinil Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Treprostinil Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Treprostinil Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Treprostinil Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Treprostinil Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Treprostinil Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Treprostinil Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Treprostinil Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Treprostinil Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Treprostinil Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Treprostinil Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Treprostinil Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Treprostinil Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Treprostinil Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Treprostinil Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Treprostinil Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Sandoz
  2. 8.1.1 Sandoz Company Information
  3. 8.1.2 Sandoz Business Overview
  4. 8.1.3 Sandoz Treprostinil Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Sandoz Treprostinil Product Portfolio
  6. 8.1.5 Sandoz Recent Developments
  7. 8.2 Anhui Medipharm Co., Ltd.
  8. 8.2.1 Anhui Medipharm Co., Ltd. Company Information
  9. 8.2.2 Anhui Medipharm Co., Ltd. Business Overview
  10. 8.2.3 Anhui Medipharm Co., Ltd. Treprostinil Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Anhui Medipharm Co., Ltd. Treprostinil Product Portfolio
  12. 8.2.5 Anhui Medipharm Co., Ltd. Recent Developments
  13. 8.3 United Therapeutics Corporation
  14. 8.3.1 United Therapeutics Corporation Company Information
  15. 8.3.2 United Therapeutics Corporation Business Overview
  16. 8.3.3 United Therapeutics Corporation Treprostinil Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 United Therapeutics Corporation Treprostinil Product Portfolio
  18. 8.3.5 United Therapeutics Corporation Recent Developments
  19. 8.4 TYVASO
  20. 8.4.1 TYVASO Company Information
  21. 8.4.2 TYVASO Business Overview
  22. 8.4.3 TYVASO Treprostinil Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 TYVASO Treprostinil Product Portfolio
  24. 8.4.5 TYVASO Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Treprostinil Value Chain Analysis
  2. 9.1.1 Treprostinil Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Treprostinil Sales Mode & Process
  6. 9.2 Treprostinil Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Treprostinil Distributors
  9. 9.2.3 Treprostinil Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst